Frontlight ResearchEarly access
Trial site
National Hospital Organization Yamaguchi Ube Medical Center
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Phase
- Phase 35 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- Pfizer2 trials
- BioNTech SE1 trial
- North East Japan Study Group1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026